Even with verifiable, peer-reviewed science, a brand's success hinges on translating complex technical details into a simple, emotionally compelling story. Aramore's CEO admits that having "the real science" is only half the battle; the "unlock" is the storytelling.

Technologically superior solutions often fail against competitors with better marketing and a stronger customer-centric narrative. For scientist-founders, it's a difficult but essential lesson to move beyond 'scientific elegance' and understand that technology, no matter how brilliant, does not sell itself.

The transition from academia to entrepreneurship is most successful when the focus shifts from pure science or technology to solving a tangible, pre-existing clinical problem. This ensures market interest, clinical adoption, and ultimately, patient impact from the outset.

A common pitfall for founders transitioning from a PhD is creating pitch decks that are essentially scientific presentations. Investors are less interested in how the technology works and more interested in the magnitude of the problem it solves and the market's demand for that solution. The 'what' and 'why' trump the 'how'.

Technologists often fail to get project approval by focusing on specs and data. A successful pitch requires a "narrative algorithm" that addresses five key drivers: empathy, engagement, alignment, evidence, and impact. This framework translates technical achievements into a compelling business story for leadership.

Scientific founders must shift from detailing R&D progress to telling a compelling story. Investors are less moved by specific experimental results and more by the vision of a platform technology at the cusp of major trends (like SynBio and AI) that can generate a continuous pipeline of future therapies.

While passion for helping patients is a powerful motivator, founders must learn to frame their pitch around value creation for investors. This means explicitly connecting the science and clinical benefit to the commercial market, reimbursement strategy, and ultimate financial return for their limited partners.

For scientists becoming entrepreneurs, the biggest shock isn't the business logistics, but the need for salesmanship. This requires shifting from deep, analytical 'how' conversations to a broader, persuasive style that feels unnatural for those accustomed to letting data speak for itself.

CEO Derek Adams describes his difficult but necessary transition from an engineer focused on objective problems to a CEO who paints a compelling vision. This involves shifting from communicating technical challenges to inspiring belief in future possibilities, a crucial skill for attracting investors and talent.